A PYMNTS Company

US: Pharma pay-for-delay class action settles

By  |  September 3, 2013

Bayer Corporation, sued along with other pharmaceutical companies in a class action for allegations of pay-for-delay contracts and non-compete agreements, has partially settled with plaintiffs for $74 million, though the additional defendants have yet to reach a similar agreement.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Bayer, along with Barr, Hoechst Marion Roussel, Watson Pharmaceuticals and The Rugby Group, were brought to court for so-called pay-for-delay agreements, alleged to have paid the generic makers of an antibiotic called Cipro to delay sales; the drug companies are refuting the claims.

    Members of the class involve buyers of Cipro within California between January 8, 1977 and October 31, 2004.

    Full Content: PR Newswire

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.